Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TapImmune
Jacksonville, Florida, United Statestapimmune.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
TapImmune was a clinical-stage immuno-oncology company developing innovative peptide and gene-based vaccines targeting folate receptor alpha for ovarian and triple-negative breast cancer. Its lead program, TPIV200, advanced through multiple Phase II studies showing safety and immune response. In late 2018, TapImmune merged with Marker Therapeutics to form a new entity focused on non-genetically engineered multi-antigen T cell therapies for solid tumors and hematologic malignancies. The combined company’s pipeline includes both legacy peptide vaccines from TapImmune and adoptive T-cell therapies from Marker.
- Therapeutic areas
- HematologyOncology
- Modalities
- Peptide vaccineGene-based immunotherapeuticVaccineCell therapy
- Industry
- Biotech
02
Partnerships
Medimmune/AstraZeneca (durvalumab combination trial)Mayo Clinic (clinical trial sponsorship/funding)Baylor College of Medicine (strategic alliance post-merger)
Beyond the preview
Go deeper on TapImmune.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TapImmune.